Aurobindo gains approval for its generic Astepro

Press enter to search
Close search
Open Menu

Aurobindo gains approval for its generic Astepro

By Sandra Levy - 11/18/2020

The Food and Drug Administration has cleared Aurobindo’s azelastine hydrochloride nasal spray in a dosage strength of 0.15% (205.5 mcg per spray).

The medication is the generic of Mylan Specialty’s Astepro nasal spray.

It is indicated for the relief of the symptoms of seasonal allergic rhinitis in patients 6 years of age and older and perennial allergic rhinitis in patients 6 years old and older.

Related Topics